During the past decade, KBC Rijeka conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 6 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 2 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "KBC Rijeka" #1 sponsor was "Actelion" with 2 trials, followed by "Boehringer Ingelheim" with 2 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored, "Gruppo Italiano Malattie EMatologiche dell'Adulto" with 1 trials sponsored and "Helsinn Healthcare SA" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "KBC Rijeka" #1 collaborator was "Incyte Corporation" with 2 trials as a collaborator, "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials as a collaborator and "Parexel" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "KBC Rijeka" are "Pulmonary Arterial Hypertension" (2 trials), "Systemic Lupus Erythematosus" (2 trials), "Abdominal Surgery" (1 trials), "Acute Myeloid Leukemia" (1 trials) and "Aortic Valve Stenosis" (1 trials). Many other conditions were trialed in "KBC Rijeka" in a lesser frequency.

Most popular intervention types in "KBC Rijeka" are "Drug" (11 trials), "Other" (3 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Baricitinib" (2 trials), "1.25 g PA21 (250 mg iron)" (1 trials), "10.0 g PA21 (2,000 mg iron)" (1 trials) and "12.5 g PA21 (2,500 mg iron)" (1 trials). Other intervention names were less common.

The vast majority of trials in "KBC Rijeka" are 13 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "KBC Rijeka". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in KBC Rijeka, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in KBC Rijeka, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".